2 results match your criteria: "Norfolk and Norwich University Hospital National Health Service (NHS) Foundation Trust[Affiliation]"
Jejunal Diverticulosis Presenting With Small Bowel Obstruction: A Diagnostic Challenge.
Cureus
March 2024
Colorectal Surgery, Norfolk and Norwich University Hospital National Health Service (NHS) Foundation Trust, Norwich, GBR.
We report the case of a woman presenting with small bowel obstruction secondary to an enterolith that formed within a jejunal diverticulum. Prior to this acute presentation, the patient had experienced regular abdominal pain albeit not as severe as the current episode. The CT scan on admission required review by two consultant radiologists before the cause of the small bowel obstruction was diagnosed.
View Article and Find Full Text PDFIs Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis? A Randomized Control Trial.
J Rheumatol
July 2015
From the Department of Rheumatology, Norfolk and Norwich University Hospital National Health Service (NHS) Foundation Trust; Norwich Medical School, University of East Anglia, Norwich; ICON Commercialisation and Outcomes, Oxford; James Paget University Hospital, Gorleston, UK.M. Yates, BSc(Hons), MBBS, MSc, MRCP, Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, and Norwich Medical School, University of East Anglia; L.E. Hamilton, BM BCh, MD, MRCP; F. Elender, BSc, PhD; L. Dean, PGDip, Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust; H. Doll, MSc, DPhil, Norwich Medical School, University of East Anglia, and ICON Commercialisation and Outcomes; A.J. MacGregor, MBBS, MD, PhD, FRCP, Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, and Norwich Medical School, University of East Anglia; J. Thomas, MBBS, MD, FRCP, James Paget University Hospital; K. Gaffney, MB ChB, BAO(Hons), FEGEMS, FRCPI, FRCP, Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust.
Objective: To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.
Methods: Adults with AS not responding to conventional therapies were prescribed ETN 50 mg once weekly for 6 months. Responders as defined by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were randomly assigned to taper to 25 mg once weekly or continue on 50 mg and followed for a further 6 months.